Endophytic Actinobacteria from the Brazilian Medicinal Plant Lychnophora ericoides Mart. and the Biological Potential of Their Secondary Metabolites

Chem Biodivers. 2016 Jun;13(6):727-36. doi: 10.1002/cbdv.201500225. Epub 2016 May 20.

Abstract

Endophytic actinobacteria from the Brazilian medicinal plant Lychnophora ericoides were isolated for the first time, and the biological potential of their secondary metabolites was evaluated. A phylogenic analysis of isolated actinobacteria was accomplished with 16S rRNA gene sequencing, and the predominance of the genus Streptomyces was observed. All strains were cultured on solid rice medium, and ethanol extracts were evaluated with antimicrobial and cytotoxic assays against cancer cell lines. As a result, 92% of the extracts showed a high or moderate activity against at least one pathogenic microbial strain or cancer cell line. Based on the biological and chemical analyses of crude extracts, three endophytic strains were selected for further investigation of their chemical profiles. Sixteen compounds were isolated, and 3-hydroxy-4-methoxybenzamide (9) and 2,3-dihydro-2,2-dimethyl-4(1H)-quinazolinone (15) are reported as natural products for the first time in this study. The biological activity of the pure compounds was also assessed. Compound 15 displayed potent cytotoxic activity against all four tested cancer cell lines. Nocardamine (2) was only moderately active against two cancer cell lines but showed strong activity against Trypanosoma cruzi. Our results show that endophytic actinobacteria from L. ericoides are a promising source of bioactive compounds.

Keywords: Actinobacteria; Biological activity; Endophytes; Lychnophora ericoides; Natural products.

MeSH terms

  • Actinobacteria / chemistry
  • Actinobacteria / isolation & purification*
  • Actinobacteria / metabolism*
  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / isolation & purification
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Antiprotozoal Agents / chemistry
  • Antiprotozoal Agents / isolation & purification
  • Antiprotozoal Agents / pharmacology*
  • Asteraceae / microbiology*
  • Biological Products / chemistry
  • Biological Products / isolation & purification
  • Biological Products / pharmacology*
  • Brazil
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Humans
  • Molecular Structure
  • Parasitic Sensitivity Tests
  • Plants, Medicinal / microbiology
  • Secondary Metabolism*
  • Structure-Activity Relationship
  • Trypanosoma cruzi / drug effects

Substances

  • Antineoplastic Agents, Phytogenic
  • Antiprotozoal Agents
  • Biological Products

Associated data

  • GENBANK/AB045871
  • GENBANK/AB184864
  • GENBANK/AJ781349
  • GENBANK/EU521699
  • GENBANK/FQ859185
  • GENBANK/HQ267989
  • GENBANK/JX483762
  • GENBANK/KC462527
  • GENBANK/KP096300
  • GENBANK/KP126291
  • GENBANK/KP126349
  • GENBANK/NR043821
  • GENBANK/NR043830
  • GENBANK/NR102948
  • GENBANK/NR112524
  • GENBANK/NR118282
  • GENBANK/NR118868
  • GENBANK/U93318